Skip to main content

Advertisement

Log in

A systematic review of prognosis predictive role of radiomics in pancreatic cancer: heterogeneity markers or statistical tricks?

  • Oncology
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

We aimed to systematically evaluate the prognostic prediction accuracy of radiomics features extracted from pre-treatment imaging in patients with pancreatic ductal adenocarcinoma (PDAC).

Methods

Radiomics literature on overall survival (OS) prediction of PDAC were all included in this systematic review. A further meta-analysis was performed on the effect size of first-order entropy. Methodological quality and risk of bias of the included studies were assessed by the radiomics quality score (RQS) and prediction model risk of bias assessment tool (PROBAST).

Results

Twenty-three studies were finally identified in this review. Two (8.7%) studies compared prognosis prediction ability between radiomics model and TNM staging model by C-index, and both showed a better performance of the radiomics. Twenty-one (91.3%) studies reported significant predictive values of radiomics features. Nine (39.1%) studies were included in the meta-analysis, and it showed a significant correlation between first-order entropy and OS (HR 1.66, 95%CI 1.18–2.34). RQS assessment revealed validation was only performed in 5 (21.7%) studies on internal datasets and 2 (8.7%) studies on external datasets. PROBAST showed that 22 (95.7%) studies have a high risk of bias in participants because of the retrospective study design.

Conclusion

First-order entropy was significantly associated with OS and might improve the accuracy of PDAC prognosis prediction. Existing studies were poorly validated, and it should be noted in future studies. Modification of PROBAST for radiomics studies is necessary since the strict requirements of prospective study design may not be applicable to the demand for a large sample size in the model construction stage.

Key Points

• Radiomics based on the primary lesion holds great potential for prognosis prediction. First-order entropy was significantly associated with the overall survival of PDAC and might improve the accuracy of current PDAC prognosis prediction.

• We strongly recommend that at least an internal validation should be conducted in any radiomics study. Attention should be paid to the complex relationships between radiomics features.

• Due to the close relationship between radiomics and big data, the strict requirement of prospective study design in PROABST may not be appropriate for radiomics studies. A balance between study types and sample sizes for radiomics studies needs to be found in the model construction stage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

AJCC:

American Joint Committee on Cancer

CI:

Confidence interval

GLCM:

Gray level co-occurrence matrix

GLSZM:

Gray level size zone matrix

HR:

Hazard ratio

ICC:

Intraclass correlation coefficient

OS:

Overall survival

PC:

Pancreatic cancer

PDAC:

Pancreatic ductal adenocarcinoma

PROBAST:

Prediction model risk of bias assessment tool

PROSPERO:

International Prospective Register of Systematic Reviews

RECIST:

Response evaluation criteria in solid tumor

ROB:

Risk of bias

ROI:

Region of interest

RQS:

Radiomics quality score

TNM:

Tumor-node-metastasis

References

  1. Saad AM, Turk T, Al-Husseini MJ, Abdel-Rahman O (2018) Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study. BMC Cancer 18:688

    PubMed  PubMed Central  Google Scholar 

  2. Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer Statistics, 2021. CA Cancer J Clin 71:7–33

    PubMed  Google Scholar 

  3. Sun H, Ma H, Hong G, Sun H, Wang J (2014) Survival improvement in patients with pancreatic cancer by decade: a period analysis of the SEER database, 1981-2010. Sci Rep 4:6747

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Mahul B, Amin SBE, Greene FL, Byrd DR, Brookland RK (2017) In: Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Milburn Jessup J, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR (eds) AJCC Cancer Staging Manual, 8th edn, Springer, Cham

  5. Shi S, Hua J, Liang C et al (2019) Proposed Modification of the 8th Edition of the AJCC Staging System for Pancreatic Ductal Adenocarcinoma. Ann Surg 269:944–950

    PubMed  Google Scholar 

  6. Tol JA, Gouma DJ, Bassi C et al (2014) Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS). Surgery 156:591–600

    PubMed  Google Scholar 

  7. Fu N, Wang W, Cheng D et al (2021) Original study: the rescue staging for pancreatic ductal adenocarcinoma with inadequate examined lymph nodes. Pancreatology 21:724–730

    PubMed  Google Scholar 

  8. Cros J, Raffenne J, Couvelard A, Pote N (2018) Tumor heterogeneity in pancreatic adenocarcinoma. Pathobiology 85:64–71

    CAS  PubMed  Google Scholar 

  9. Marusyk A, Polyak K (2010) Tumor heterogeneity: causes and consequences. Biochim Biophys Acta 1805:105–117

    CAS  PubMed  Google Scholar 

  10. Marusyk A, Almendro V, Polyak K (2012) Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer 12:323–334

    CAS  PubMed  Google Scholar 

  11. Gerlinger M, Rowan AJ, Horswell S et al (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:883–892

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, They Are Data. Radiology 278:563–577

    PubMed  Google Scholar 

  13. Lambin P, Leijenaar RTH, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14:749–762

    Article  PubMed  Google Scholar 

  14. Aerts HJ (2016) The potential of radiomic-based phenotyping in precision medicine: a review. JAMA Oncol 2:1636–1642

    PubMed  Google Scholar 

  15. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62:1006–1012

    PubMed  Google Scholar 

  16. Wolff RF, Moons KGM, Riley RD et al (2019) PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med 170:51–58

    PubMed  Google Scholar 

  17. Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558

    PubMed  Google Scholar 

  18. Conover WJ (1999) Practical nonparametric statistics, 3rd edn. Wiley, New York

    Google Scholar 

  19. Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:455–463

    CAS  PubMed  Google Scholar 

  20. Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15:155–163

    PubMed  PubMed Central  Google Scholar 

  21. Zhong J, Hu Y, Si L et al (2021) A systematic review of radiomics in osteosarcoma: utilizing radiomics quality score as a tool promoting clinical translation. Eur Radiol 31:1526–1535

    PubMed  Google Scholar 

  22. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174

    CAS  PubMed  Google Scholar 

  23. Cen C, Liu L, Li X et al (2021) Pancreatic ductal adenocarcinoma at CT: a combined nomogram model to preoperatively predict cancer stage and survival outcome. Front Oncol 11:594510

    PubMed  PubMed Central  Google Scholar 

  24. Cheng S-H, Cheng Y-J, Jin Z-Y, Xue H-D (2019) Unresectable pancreatic ductal adenocarcinoma: role of CT quantitative imaging biomarkers for predicting outcomes of patients treated with chemotherapy. Eur J Radiol 113:188–197

    PubMed  Google Scholar 

  25. Choi MH, Lee YJ, Yoon SB, Choi J-I, Jung SE, Rha SE (2019) MRI of pancreatic ductal adenocarcinoma: texture analysis of T2-weighted images for predicting long-term outcome. Abdom Radiol (NY) 44:122–130

  26. Cozzi L, Comito T, Fogliata A et al (2019) Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma. PLoS One 14:e0210758

  27. Cui Y, Song J, Pollom E et al (2016) Quantitative analysis of 18F-fluorodeoxyglucose positron emission tomography identifies novel prognostic imaging biomarkers in locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 96:102–109

    PubMed  Google Scholar 

  28. De Robertis R, Beleù A, Cardobi N et al (2020) Correlation of MR features and histogram-derived parameters with aggressiveness and outcomes after resection in pancreatic ductal adenocarcinoma. Abdom Radiol (NY) 45:3809–3818

    PubMed  Google Scholar 

  29. Eilaghi A, Baig S, Zhang Y et al (2017) CT texture features are associated with overall survival in pancreatic ductal adenocarcinoma - a quantitative analysis. BMC Med Imaging 17:38

    PubMed  PubMed Central  Google Scholar 

  30. Hang J, Xu K, Yin R et al (2021) Role of CT texture features for predicting outcome of pancreatic cancer patients with liver metastases. J Cancer 12:2351–2358

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Healy GM, Salinas-Miranda E, Jain R et al (2021) Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation. Eur Radiol 32:2492–2505

  32. Hyun SH, Kim HS, Choi SH et al (2016) Intratumoral heterogeneity of (18)F-FDG uptake predicts survival in patients with pancreatic ductal adenocarcinoma. Eur J Nucl Med Mol Imaging 43:1461–1468

    CAS  PubMed  Google Scholar 

  33. Kaissis G, Ziegelmayer S, Lohöfer F et al (2019) A machine learning model for the prediction of survival and tumor subtype in pancreatic ductal adenocarcinoma from preoperative diffusion-weighted imaging. Eur Radiol Exp 3:41

    PubMed  PubMed Central  Google Scholar 

  34. Khalvati F, Zhang Y, Baig S et al (2019) Prognostic Value of CT Radiomic Features in Resectable Pancreatic Ductal Adenocarcinoma. Sci Rep 9:5449

    PubMed  PubMed Central  Google Scholar 

  35. Kim BR, Kim JH, Ahn SJ et al (2019) CT prediction of resectability and prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant treatment using image findings and texture analysis. Eur Radiol 29:362–372

    PubMed  Google Scholar 

  36. Kim HS, Kim YJ, Kim KG, Park JS (2019) Preoperative CT texture features predict prognosis after curative resection in pancreatic cancer. Sci Rep 9:17389

    PubMed  PubMed Central  Google Scholar 

  37. Lee JW, Park SH, Ahn H, Lee SM, Jang SJ (2021) Predicting survival in patients with pancreatic cancer by integrating bone marrow fdg uptake and radiomic features of primary tumor in pet/ct. Cancers 13:3563

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Parr E, Du Q, Zhang C et al (2020) Radiomics-Based Outcome Prediction for Pancreatic Cancer Following Stereotactic Body Radiotherapy. Cancers 12:1051

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Sandrasegaran K, Lin Y, Asare-Sawiri M, Taiyini T, Tann M (2019) CT texture analysis of pancreatic cancer. Eur Radiol 29:1067–1073

    PubMed  Google Scholar 

  40. Smeets EMM, Withaar DS, Grootjans W et al (2019) Optimal respiratory-gated [18F]FDG PET/CT significantly impacts the quantification of metabolic parameters and their correlation with overall survival in patients with pancreatic ductal adenocarcinoma. EJNMMI Res 9:24

    PubMed  PubMed Central  Google Scholar 

  41. Toyama Y, Hotta M, Motoi F, Takanami K, Minamimoto R, Takase K (2020) Prognostic value of FDG-PET radiomics with machine learning in pancreatic cancer. Sci Rep 10:17024

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Xie T, Wang X, Li M, Tong T, Yu X, Zhou Z (2020) Pancreatic ductal adenocarcinoma: a radiomics nomogram outperforms clinical model and TNM staging for survival estimation after curative resection. Eur Radiol 30:2513–2524

    PubMed  Google Scholar 

  43. Yoo M, Yoon Y-S, Md P et al (2020) Prognosis prediction of pancreatic cancer after curative intent surgery using imaging parameters derived from F-18 fluorodeoxyglucose positron emission tomography/computed tomography. Medicine (Baltimore) 99:e21829

    CAS  PubMed  Google Scholar 

  44. Yoo SH, Kang SY, Cheon GJ, Oh D-Y, Bang Y-J (2020) Predictive role of temporal changes in intratumoral metabolic heterogeneity during palliative chemotherapy in patients with advanced pancreatic cancer: a prospective cohort study. J Nucl Med 61:33–39

  45. Yue Y, Osipov A, Fraass B et al (2017) Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients. J Gastrointest Oncol 8:127–138

    PubMed  PubMed Central  Google Scholar 

  46. Davnall F, Yip CS, Ljungqvist G et al (2012) Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging 3:573–589

    PubMed  PubMed Central  Google Scholar 

  47. Yip C, Landau D, Kozarski R et al (2014) Primary esophageal cancer: heterogeneity as potential prognostic biomarker in patients treated with definitive chemotherapy and radiation therapy. Radiology 270:141–148

    PubMed  Google Scholar 

  48. Ganeshan B, Skogen K, Pressney I, Coutroubis D, Miles K (2012) Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. Clin Radiol 67:157–164

    CAS  PubMed  Google Scholar 

  49. Ng F, Ganeshan B, Kozarski R, Miles KA, Goh V (2013) Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. Radiology 266:177–184

    PubMed  Google Scholar 

  50. Ahn SY, Park CM, Park SJ et al (2015) Prognostic value of computed tomography texture features in non-small cell lung cancers treated with definitive concomitant chemoradiotherapy. Invest Radiol 50:719–725

  51. Yu Y, Tan Y, Xie C et al (2020) Development and validation of a preoperative magnetic resonance imaging radiomics-based signature to predict axillary lymph node metastasis and disease-free survival in patients with early-stage breast cancer. JAMA Netw Open 3:e2028086

    PubMed  PubMed Central  Google Scholar 

  52. Ganeshan B, Miles KA, Young RC, Chatwin CR (2007) In search of biologic correlates for liver texture on portal-phase CT. Acad Radiol 14:1058–1068

    PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to express their gratitude to Prof. Jingmei Jiang and Prof. Lu Yin for their teaching of statistics in the early stage of this systematic review.

Funding

This study has received funding from the National Natural Science Foundation of China (grant number 81871512) and the Sky Imaging Research Fund of the Chinese International Medical Foundation (grant number z-2014-07-1912-08).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Huadan Xue.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Huadan Xue.

Conflict of interest

The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.

Statistics and biometry

One of the authors has significant statistical expertise.

Informed consent

Written informed consent was not available for this study because the nature of our study was a systematic review and meta-analysis.

Ethical approval

Institutional Review Board approval was not available for this study because the nature of our study was a systematic review and meta-analysis.

Methodology

• retrospective

• diagnostic or prognostic study

• multicenter study

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

(DOCX 467 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gao, Y., Cheng, S., Zhu, L. et al. A systematic review of prognosis predictive role of radiomics in pancreatic cancer: heterogeneity markers or statistical tricks?. Eur Radiol 32, 8443–8452 (2022). https://doi.org/10.1007/s00330-022-08922-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-022-08922-0

Keywords

Navigation